(Q34631380)

3 August 2017

1 reference

title

Epidemiology and prophylaxis of viral hepatitis: a global perspective (English)

1 reference

3 August 2017

1 reference

1 reference

1 reference

Yong Poovorawan

1

0 references

Voranush Chongsrisawat

series ordinal

3

object named as

Voranush Chongsrisawat

1 reference

3 August 2017

Pantipa Chatchatee

2

1 reference

3 August 2017

1 February 2002

1 reference

Journal of Gastroenterology and Hepatology

3 August 2017

1 reference

3 August 2017

17 Suppl

1 reference

3 August 2017

S155-66

1 reference

Epidemiological patterns of hepatitis A in different parts of the world

3 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis A shifting epidemiology in South-East Asia and China

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

The prevalence of antibody to hepatitis A virus in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

History and epidemiology of hepatitis A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis A shifting epidemiology in the Middle East and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Sociodemographic factors and the declining prevalence of anti-hepatitis A antibodies in young adults in Israel: implications for the new hepatitis A vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Secular trends in hepatitis A virus infection among Alaska Natives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis A immunity in the Swedish population. A study of the prevalence of markers in the Swedish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis B epidemiology in Asia, the Middle East and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Epidemiology of hepatitis B infection in the Western Pacific and South East Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

The origin and evolution of hepatitis viruses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Infant and adolescent hepatitis B immunization up to 1999: a global overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Introduction to the regional workshops

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

A survey on the vaccination practice for perinatal hepatitis B virus infection at a clinic in Okinawa, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

From Cannes 1993 to the present

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Report on Working Group 1: Albania, Andorra, Canada, France, Italy, Moldova, Portugal, Poland, Romania and Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Report on Working Group 2: Austria, Belgium, Bulgaria, Germany, Greece, Hungary, Malta, Russia, Switzerland, Turkey and Uzbekistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Control of hepatitis B in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Universal childhood hepatitis B vaccination: infants vs. preadolescents, the Canadian perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Are booster immunisations needed for lifelong hepatitis B immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis B vaccination and hepatocellular carcinoma in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Nationwide vaccination: a success story in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Heterosexual transmission of hepatitis C virus and the possible role of coexistent human immunodeficiency virus infection in the index case. A multicentre study of 423 pairings

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Vaccine development for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

A genotype of hepatitis D virus that occurs in northern South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis D virus infection in Thailand: HDV genotyping by RT-PCR, RFLP and direct sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Hepatitis E: intrafamilial transmission versus waterborne spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Epidemiology of hepatitis E virus infection in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Role of immune serum globulins in pregnant women during an epidemic of hepatitis E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Infection with hepatitis G virus among recipients of plasma products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

High prevalence of hepatitis G virus infection in multiply transfused children with thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Infection with hepatitis GB virus C in patients on maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Mother-to-infant transmission of GB virus type C/HGV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Heterosexual transmission of GB virus C/hepatitis G virus infection to non-intravenous drug-using female prostitutes in Fukuoka, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Sexual transmission of GB virus C/hepatitis G virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Clearance of hepatitis G virus infection in thalassaemic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Cloning the differences between two complex genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Determination of antibodies to TT virus (TTV) and application to blood donors and patients with post-transfusion non-A to G hepatitis in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Prevalence of transmitted transfusion virus (TTV) in populations at different risk for hepatitis virus: hemodialysis, chronic hepatitis C and cryptogenetic hepatitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

The role of TT virus infection in acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Association of hepatitis viruses with hepatocellular carcinoma in Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

TT virus infection in gibbons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

TT virus infection in nonhuman primates and characterization of the viral genome: identification of simian TT virus isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Species-specific TT viruses in humans and nonhuman primates and their phylogenetic relatedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

High prevalence of TT virus-related DNA (90%) and diverse viral genotypes in Norwegian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Impact of hepatitis B immunisation as part of the EPI

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.17.S1.4.X

10.1046/J.1440-1746.17.S1.4.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12000601